Annovis Bio, Inc. — Investor Relations & Filings
Filings indexed
290
across all filing types
Latest filing
2026-05-20
Regulatory Filings
Country
US
United States of America
Listing
US
ANVS
Annovis Bio, Inc. is a clinical-stage drug platform company that develops therapies for neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD). Its lead product candidate, buntanetap, is a translational inhibitor designed to halt the death of nerve cells by targeting the synthesis of multiple neurotoxic proteins. The company's therapeutic approach aims to restore nerve cell function, with the goal of improving cognitive and motor abilities in patients suffering from neurodegeneration.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 46691547 | FORM 8-K | 2026-05-20 | English | ||
| 46691545 | 424B5 | 2026-05-20 | English | ||
| 46559848 | 424B5 | 2026-05-19 | English | ||
| 46362836 | 10-Q | 2026-05-15 | English | ||
| 46361439 | FORM 8-K | 2026-05-15 | English | ||
| 33940010 | 424B5 - Annovis Bio, Inc. (0001477845) (Filer) | 2026-04-09 | English | ||
| 33043098 | 8-K - Annovis Bio, Inc. (0001477845) (Filer) | 2026-03-25 | English | ||
| 30034997 | 8-K Filing | 2026-02-12 | English | ||
| 30034999 | 8-K Filing | 2026-01-28 | English | ||
|
2025
6 filings
| |||||
| 12326726 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 12326730 | OWNERSHIP DOCUMENT | 2025-11-25 | English | ||
| 12326728 | OWNERSHIP DOCUMENT | 2025-11-25 | English | ||
| 12326727 | OWNERSHIP DOCUMENT | 2025-11-21 | English | ||
| 12326729 | OWNERSHIP DOCUMENT | 2025-11-18 | English | ||
| 12326731 | 8-K | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
Annovis Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34695/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34695 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34695 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34695 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34695}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Annovis Bio, Inc. (id: 34695)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.